Friday 6 November 2026
Export AVTR’s income statement to Excel — free account
Avantor, Inc.
AVTR Healthcare Medical Instruments & Supplies
Avantor, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $6.6 billion, down 3.41% from fiscal 2024.
- Revenue
- +4.59%
- EPS
- +128.9%
- Free cash flow
- −9.03%
- Total debt
- −4.51%
Quarter to September 2026, against a year earlier
15.14
0.51
−3.26%
Follow AVTR
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
4 | 5 | 5 | 7 |
| (9.20%) | (9.44%) | (9.70%) | 5.91% | ||
| (4.44%) | (4.60%) | (4.74%) | 2.89% | ||
ROIC |
(1.68%) | (2.01%) | (2.09%) | 3.36% | |
Return on Tangible Assets |
(28.83%) | (30.58%) | (31.20%) | 16.84% | |
Average Days of Receivables |
59.86 | 61.54 | 63.36 | 61.77 | |
Free Cash Flow per Share |
0.73 | 0.65 | 0.67 | 0.65 | |
Free Cash Flow |
495.00 | 438.90 | 454.70 | 439.20 | |
Capital Expenditures |
(128.80) | (134.30) | (142.30) | (145.50) | |
| Other line items | |||||
Cash ROIC |
5.01% | 4.53% | 4.72% | 4.40% | |
Accounts Receivable Turnover |
6.21 | 5.95 | 5.73 | 6.03 | |
Accounts Payable Turnover |
6.28 | 6.28 | 6.16 | 6.36 | |
Inventory Turnover |
5.70 | 5.70 | 5.56 | 5.50 | |
Average Days of Payables |
61.35 | 60.37 | 60.65 | 59.13 | |
Days of Inventory on Hand |
67.68 | 66.51 | 67.62 | 68.74 | |
Tax Rate |
0.20 | 0.17 | 0.22 | 0.07 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
24.35% | 24.56% | 24.37% | 24.17% | |
Share Based Compensation of Revenue |
0.71% | 0.65% | 0.65% | 0.72% | |
Interest Coverage |
(1.45) | (1.72) | (1.81) | 3.00 | |
Operating CF/Net income |
(1.18) | (1.04) | (1.03) | 1.73 | |
Depreciation/Fixed assets |
0.55 | 0.55 | 0.55 | 0.55 | |
Capex/Depreciation |
(0.31) | (0.32) | (0.33) | (0.34) | |
Revenue per Share |
9.63 | 9.70 | 9.70 | 9.80 | |
Operating CF per Share |
0.92 | 0.85 | 0.88 | 0.86 | |
Capex per Share |
(0.19) | (0.20) | (0.21) | (0.21) | |
Capex to Sales |
0.02 | 0.02 | 0.02 | 0.02 |
Columns are period end dates · fundamentals updated 5 Nov 2026